Lopinavir suppliers
Lopinavir
- CAS:
- 192725-17-0
- MF:
- C37H48N4O5
- MW:
- 628.81
Suppliers by country/region
Company Type
Properties
- Melting point:
- 255.2-260.6 °F (124—127°C)
- Boiling point:
- 924.1±65.0 °C(Predicted)
- Density
- 1.163±0.06 g/cm3(Predicted)
- storage temp.
- 2-8°C
- solubility
- DMSO: soluble20mg/mL, clear
- form
- powder
- pka
- 13.89±0.46(Predicted)
- color
- white to beige
- optical activity
- [α]/D -20 to -27°, c = 0.4 in methanol
- Stability:
- Hygroscopic
Safety Information
- Symbol(GHS)
GHS07,GHS08
- Signal word
- Warning
- Hazard statements
- H315-H373-H319-H335
- Precautionary statements
- P264-P280-P302+P352-P321-P332+P313-P362-P264-P280-P305+P351+P338-P337+P313P-P260-P314-P501
- RIDADR
- 3077
- HS Code
- 29335990
Use
Lopinavir, the sixth HIV protease inhibitor in the “navir” class, was launched in coformulation with ritonavir, another HIV protease inhibitor already marketed (Abbott, 1996); this original formulation was introduced as Kaletra for use in combination with either nucleoside or non-nucleoside reverse transcriptase inhibitors for the treatment of AIDS in adults and children. Lopinavir is a peptidomimetic compound with a structural core identical to that of ritonavir, on which terminal groups, particularly a modified valine, were introduced by peptide coupling procedures. Lopinavir is a potent competitive inhibitor of HIV-I protease exhibiting high potential against ritonavir-resistant mutations.
284 supplier list of "Lopinavir"